Annual EBITDA
-$6.13 M
+$14.73 M+70.61%
31 May 2024
Summary:
AngioDynamics annual earnings before interest, taxes, depreciation & amortization is currently -$6.13 million, with the most recent change of +$14.73 million (+70.61%) on 31 May 2024. During the last 3 years, it has risen by +$3.14 million (+33.89%). ANGO annual EBITDA is now -116.43% below its all-time high of $37.32 million, reached on 31 May 2014.ANGO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.93 M
-$2.94 M-290.32%
31 August 2024
Summary:
AngioDynamics quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.93 million, with the most recent change of -$2.94 million (-290.32%) on 31 August 2024. Over the past year, it has dropped by -$1.90 million (-7307.69%). ANGO quarterly EBITDA is now -109.02% below its all-time high of $21.36 million, reached on 30 November 2016.ANGO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$5.02 M
+$1.12 M+18.20%
31 August 2024
Summary:
AngioDynamics TTM earnings before interest, taxes, depreciation & amortization is currently -$5.02 million, with the most recent change of +$1.12 million (+18.20%) on 31 August 2024. Over the past year, it has dropped by -$9.58 million (-209.83%). ANGO TTM EBITDA is now -110.61% below its all-time high of $47.27 million, reached on 28 February 2017.ANGO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANGO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +70.6% | -7307.7% | -209.8% |
| 3 y3 years | +33.9% | -36.6% | +67.9% |
| 5 y5 years | -137.7% | -172.9% | -125.9% |
ANGO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7068.2% | +70.6% | -115.8% | +66.9% | -137.8% | +69.2% |
| 5 y | 5 years | -137.7% | +95.7% | -115.8% | +98.7% | -125.9% | +96.6% |
| alltime | all time | -116.4% | +95.7% | -109.0% | +98.7% | -110.6% | +96.6% |
AngioDynamics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2024 | - | -$1.93 M(-290.3%) | -$5.02 M(-18.2%) |
| May 2024 | -$6.13 M(-70.6%) | $1.01 M(-124.8%) | -$6.13 M(+204.3%) |
| Feb 2024 | - | -$4.08 M(>+9900.0%) | -$2.02 M(-144.1%) |
| Nov 2023 | - | -$26.00 K(-99.1%) | $4.57 M(-49.3%) |
| Aug 2023 | - | -$3.04 M(-159.3%) | $9.00 M(+44.5%) |
| May 2023 | -$20.86 M(<-9900.0%) | $5.13 M(+104.7%) | $6.23 M(-53.1%) |
| Feb 2023 | - | $2.51 M(-43.1%) | $13.27 M(+5.4%) |
| Nov 2022 | - | $4.41 M(-175.8%) | $12.59 M(+85.9%) |
| Aug 2022 | - | -$5.82 M(-147.8%) | $6.77 M(-39.2%) |
| May 2022 | - | $12.18 M(+568.2%) | $11.13 M(-168.4%) |
| May 2022 | $88.00 K(-100.9%) | - | - |
| Feb 2022 | - | $1.82 M(-229.2%) | -$16.27 M(+4.2%) |
| Nov 2021 | - | -$1.41 M(-3.1%) | -$15.62 M(+22.9%) |
| Aug 2021 | - | -$1.46 M(-90.4%) | -$12.71 M(+37.0%) |
| May 2021 | -$9.28 M(-93.5%) | -$15.23 M(-714.6%) | -$9.28 M(-93.6%) |
| Feb 2021 | - | $2.48 M(+65.4%) | -$144.46 M(-1.6%) |
| Nov 2020 | - | $1.50 M(-24.3%) | -$146.87 M(+0.8%) |
| Aug 2020 | - | $1.98 M(-101.3%) | -$145.72 M(+1.6%) |
| May 2020 | -$143.42 M(-981.1%) | -$150.42 M(<-9900.0%) | -$143.42 M(-968.4%) |
| Feb 2020 | - | $73.00 K(-97.2%) | $16.52 M(-14.7%) |
| Nov 2019 | - | $2.64 M(-38.3%) | $19.37 M(-7.6%) |
| Aug 2019 | - | $4.28 M(-55.0%) | $20.97 M(+28.9%) |
| May 2019 | $16.28 M(+81.6%) | $9.52 M(+225.2%) | $16.28 M(-302.5%) |
| Feb 2019 | - | $2.93 M(-31.0%) | -$8.04 M(+1743.6%) |
| Nov 2018 | - | $4.25 M(-1120.4%) | -$436.00 K(-121.3%) |
| Aug 2018 | - | -$416.00 K(-97.2%) | $2.05 M(-77.2%) |
| May 2018 | $8.96 M(-32.9%) | -$14.79 M(-240.5%) | $8.96 M(-266.7%) |
| Feb 2018 | - | $10.53 M(+56.5%) | -$5.38 M(+18.1%) |
| Nov 2017 | - | $6.73 M(+3.5%) | -$4.55 M(-145.1%) |
| Aug 2017 | - | $6.50 M(-122.3%) | $10.08 M(-24.5%) |
| May 2017 | $13.36 M(-52.7%) | -$29.13 M(-356.6%) | $13.36 M(-71.7%) |
| Feb 2017 | - | $11.35 M(-46.8%) | $47.27 M(+5.9%) |
| Nov 2016 | - | $21.36 M(+118.5%) | $44.65 M(+44.9%) |
| Aug 2016 | - | $9.78 M(+104.4%) | $30.81 M(+9.1%) |
| May 2016 | $28.25 M(+13.3%) | $4.78 M(-45.2%) | $28.25 M(-8.6%) |
| Feb 2016 | - | $8.73 M(+16.1%) | $30.89 M(+55.9%) |
| Nov 2015 | - | $7.52 M(+4.4%) | $19.82 M(-14.6%) |
| Aug 2015 | - | $7.21 M(-3.0%) | $23.21 M(-6.9%) |
| May 2015 | $24.92 M(-33.2%) | $7.43 M(-417.0%) | $24.92 M(-7.0%) |
| Feb 2015 | - | -$2.34 M(-121.5%) | $26.80 M(-36.1%) |
| Nov 2014 | - | $10.92 M(+22.5%) | $41.92 M(+5.7%) |
| Aug 2014 | - | $8.92 M(-4.2%) | $39.65 M(+6.2%) |
| May 2014 | $37.32 M | $9.31 M(-27.2%) | $37.32 M(+3.1%) |
| Feb 2014 | - | $12.78 M(+47.8%) | $36.21 M(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2013 | - | $8.64 M(+31.1%) | $29.69 M(-6.8%) |
| Aug 2013 | - | $6.59 M(-19.6%) | $31.86 M(-8.3%) |
| May 2013 | $34.76 M(+241.0%) | $8.20 M(+30.9%) | $34.76 M(+43.8%) |
| Feb 2013 | - | $6.26 M(-42.1%) | $24.17 M(+31.9%) |
| Nov 2012 | - | $10.81 M(+13.9%) | $18.32 M(+27.8%) |
| Aug 2012 | - | $9.49 M(-497.3%) | $14.33 M(+40.6%) |
| May 2012 | $10.19 M(-57.1%) | -$2.39 M(-682.7%) | $10.19 M(-25.8%) |
| Feb 2012 | - | $410.00 K(-94.0%) | $13.73 M(-36.5%) |
| Nov 2011 | - | $6.82 M(+27.5%) | $21.64 M(-6.0%) |
| Aug 2011 | - | $5.35 M(+366.5%) | $23.02 M(-3.2%) |
| May 2011 | $23.78 M(-27.6%) | $1.15 M(-86.2%) | $23.78 M(-25.3%) |
| Feb 2011 | - | $8.32 M(+1.4%) | $31.85 M(-0.7%) |
| Nov 2010 | - | $8.21 M(+34.4%) | $32.06 M(-0.8%) |
| Aug 2010 | - | $6.11 M(-33.8%) | $32.33 M(-1.5%) |
| May 2010 | $32.82 M(+17.5%) | $9.22 M(+8.0%) | $32.82 M(+4.2%) |
| Feb 2010 | - | $8.53 M(+0.7%) | $31.49 M(+8.9%) |
| Nov 2009 | - | $8.48 M(+28.6%) | $28.90 M(+2.5%) |
| Aug 2009 | - | $6.59 M(-16.4%) | $28.19 M(-0.5%) |
| May 2009 | $27.94 M(+11.3%) | $7.89 M(+32.6%) | $28.33 M(+21.7%) |
| Feb 2009 | - | $5.95 M(-23.4%) | $23.27 M(-14.6%) |
| Nov 2008 | - | $7.77 M(+15.5%) | $27.24 M(+3.2%) |
| Aug 2008 | - | $6.73 M(+137.9%) | $26.40 M(+5.2%) |
| May 2008 | $25.11 M(-421.2%) | $2.83 M(-71.5%) | $25.10 M(-10.9%) |
| Feb 2008 | - | $9.92 M(+43.2%) | $28.18 M(-3653.3%) |
| Nov 2007 | - | $6.92 M(+27.5%) | -$793.00 K(-81.7%) |
| Aug 2007 | - | $5.43 M(-7.9%) | -$4.33 M(-44.6%) |
| May 2007 | -$7.82 M(-168.6%) | $5.90 M(-131.0%) | -$7.82 M(-24.0%) |
| Feb 2007 | - | -$19.05 M(-662.5%) | -$10.29 M(-186.3%) |
| Nov 2006 | - | $3.39 M(+73.9%) | $11.92 M(+6.4%) |
| Aug 2006 | - | $1.95 M(-43.2%) | $11.20 M(-1.7%) |
| May 2006 | $11.39 M(+34.0%) | $3.43 M(+8.8%) | $11.39 M(+6.6%) |
| Feb 2006 | - | $3.15 M(+18.2%) | $10.68 M(+8.3%) |
| Nov 2005 | - | $2.67 M(+24.7%) | $9.87 M(+7.4%) |
| Aug 2005 | - | $2.14 M(-21.5%) | $9.19 M(+8.1%) |
| May 2005 | $8.50 M(+46.4%) | $2.73 M(+16.6%) | $8.50 M(+8.4%) |
| Feb 2005 | - | $2.34 M(+17.8%) | $7.84 M(+19.1%) |
| Nov 2004 | - | $1.98 M(+36.5%) | $6.58 M(+43.1%) |
| Aug 2004 | - | $1.45 M(-29.7%) | $4.60 M(+46.2%) |
| May 2004 | $5.80 M(+49.0%) | $2.07 M(+92.0%) | $3.15 M(-139.6%) |
| Feb 2004 | - | $1.08 M(-111.9%) | -$7.95 M(+257.6%) |
| May 2003 | $3.90 M(+31.7%) | -$9.02 M(-232.7%) | -$2.22 M(-132.7%) |
| Feb 2003 | - | $6.80 M | $6.80 M |
| May 2002 | $2.96 M(-69.0%) | - | - |
| May 2001 | $9.55 M | - | - |
FAQ
- What is AngioDynamics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for AngioDynamics?
- What is AngioDynamics annual EBITDA year-on-year change?
- What is AngioDynamics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for AngioDynamics?
- What is AngioDynamics quarterly EBITDA year-on-year change?
- What is AngioDynamics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for AngioDynamics?
- What is AngioDynamics TTM EBITDA year-on-year change?
What is AngioDynamics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ANGO is -$6.13 M
What is the all time high annual EBITDA for AngioDynamics?
AngioDynamics all-time high annual earnings before interest, taxes, depreciation & amortization is $37.32 M
What is AngioDynamics annual EBITDA year-on-year change?
Over the past year, ANGO annual earnings before interest, taxes, depreciation & amortization has changed by +$14.73 M (+70.61%)
What is AngioDynamics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ANGO is -$1.93 M
What is the all time high quarterly EBITDA for AngioDynamics?
AngioDynamics all-time high quarterly earnings before interest, taxes, depreciation & amortization is $21.36 M
What is AngioDynamics quarterly EBITDA year-on-year change?
Over the past year, ANGO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.90 M (-7307.69%)
What is AngioDynamics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ANGO is -$5.02 M
What is the all time high TTM EBITDA for AngioDynamics?
AngioDynamics all-time high TTM earnings before interest, taxes, depreciation & amortization is $47.27 M
What is AngioDynamics TTM EBITDA year-on-year change?
Over the past year, ANGO TTM earnings before interest, taxes, depreciation & amortization has changed by -$9.58 M (-209.83%)